FTC sues important pharmacy benefit supervisors in excess of insulin costs The agency brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record price of everyday living-conserving insulin prescription drugs. Earlier this summer, the organization held prolonged negotiations with Steward https://finnbshxo.blogsuperapp.com/31155776/healthcare-news-things-to-know-before-you-buy